Wagner, Erwin F.

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation

Cell death mechanisms and regulationAutophagy in Disease and Therapy

Cited by 6,680

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell

Bone Metabolism and DiseasesSignaling Pathways in Disease

Cited by 2,701

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 1,778

Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase

Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science

Lipid metabolism and biosynthesisLipid metabolism and disorders

Cited by 1,375

A Validated Regulatory Network for Th17 Cell Specification

Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A., Huang, W., Parkurst, C. N., Muratet, M., et al. (2012) · Cell

Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

Cited by 1,160

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., et al. (2015) · Cell Death & Differentiation

Cell death mechanisms and regulationAutophagy in Disease and Therapy

Cited by 1,002

Strain-Dependent Epithelial Defects in Mice Lacking the EGF Receptor

Sibilia, M., & Wagner, E. F. (1995) · Science

HER2/EGFR in Cancer ResearchHair Growth and Disorders

Cited by 1,002

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., et al. (2005) · The Journal of Experimental Medicine

Bone Metabolism and DiseasesSignaling Pathways in Disease

Cited by 849

Fos/AP‐1 proteins in bone and the immune system

Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews

Bone Metabolism and DiseasesOsteomyelitis and Bone Disorders Research

Cited by 537

Calprotectin: from biomarker to biological function

Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut

Inflammatory Bowel DiseaseS100 Proteins and Annexins

Cited by 500

Osteoclasts are essential for TNF-α-mediated joint destruction.

Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation

Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases

Cited by 474

The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development

Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F. M., Schlessinger, J., & Wagner, E. F. (2000) · Cell

HER2/EGFR in Cancer ResearchProtein Kinase Regulation and GTPase Signaling

Cited by 304

IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss

Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L.-C., Cao, Y., Schett, G., Wagner, E. F., & Karin, M. (2005) · The Journal of Experimental Medicine

Bone Metabolism and DiseasesNF-κB Signaling Pathways

Cited by 252

c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity

Stepniak, E., Ricci, R., Eferl, R., Sumara, G., Sumara, I., Rath, M., Hui, L., & Wagner, E. F. (2006) · Genes & Development

Liver physiology and pathologyOrgan Transplantation Techniques and Outcomes

Cited by 232

JunB can substitute for Jun in mouse development and cell proliferation

Passegué, E., Jochum, W., Behrens, A., Ricci, R., & Wagner, E. F. (2002) · Nature Genetics

Developmental Biology and Gene RegulationGenomics and Chromatin Dynamics

Cited by 162

Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells

Grigoriadis, A. E., Kennedy, M., Bozec, A., Brunton, F., Stenbeck, G., Park, I.-H., Wagner, E. F., & Keller, G. M. (2010) · Blood

Bone Metabolism and DiseasesPluripotent Stem Cells Research

Cited by 151

Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment

Okada, S., Wang, Z.-Q., Grigoriadis, A. E., Wagner, E. F., & von Rüden, T. (1994) · Molecular and Cellular Biology

Hematopoietic Stem Cell TransplantationBone Metabolism and Diseases

Cited by 62

Cutaneous Immune Cell-Microbiota Interactions Are Controlled by Epidermal JunB/AP-1

Uluçkan, Ö., Jiménez, M., Roediger, B., Schnabl, J., Díez-Córdova, L. T., Troulé, K., Weninger, W., & Wagner, E. F. (2019) · Cell Reports

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 21